Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis
ConclusionsHypergammaglobulinemia identifies C‐P class A cirrhotic patients at higher risk of disease progression, HCC development and death.This article is protected by copyright. All rights reserved.
Source: Liver International - Category: Gastroenterology Authors: Irene Cacciola, Roberto Filomia, Angela Alibrandi, Maria Stella Franz è, Gaia Caccamo, Sergio Maimone, Carlo Saitta, Francesca Saffioti, Giovanni Squadrito, Giovanni Raimondo Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Child Development | Cholesterol | Cirrhosis | Diabetes | Endocrinology | Esophagogastroduodenoscopy | Esophagus Cancer | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Transplant | Study | Transplants | Urology & Nephrology